The production of cultivated meat is based on well-known biotechnological processes that are the same as in other large-scale cell culture applications. For this future market, GEMÜ offers complete valves as well as measurement and control systems from a single source.

Cultivated meat is a steadily growing market that represents an efficient and sustainable option for the future meat supply. GEMÜ is entering this market and, thanks to its expertise, is becoming a competent partner for manufacturers of cultivated meat. As with other large-scale cell culture applications, such as antibody therapeutics, one or more bioreactors, which form the heart of the system, are used in production. In addition, so-called auxiliary processes such as water treatment, filtration, heating and cooling circuits are required. As a leading global supplier of valves and control systems for the pharmaceutical, biotechnology and food industries, GEMÜ can optimally support these processes with the appropriate components and know-how.

GEMÜ offers the right solutions for the production of cultivated meat in both aseptic and non-aseptic areas.

Diaphragm valves (e.g. GEMÜ 650, GEMÜ 653, GEMÜ 687) and diaphragm globe valves (e.g. GEMÜ 657, GEMÜ F40) are mainly used for demanding, aseptic process steps such as inoculating the bioreactor or transferring the cells between the bioreactors. Drainage-optimized bottom outlet valves based on the diaphragm valve principle guarantee aseptic and low product loss cell harvesting.

For the laboratory phase in the cultivated meat sector, customer-specific and individually tailored single-use solutions guarantee the necessary process reliability and flexibility.

Auxiliary processes in which the media do not come into contact with product-contacting surfaces are non-aseptic applications and also play an important role at GEMÜ. Thanks to the extensive product portfolio, seat valves (e.g. GEMÜ 550, GEMÜ 554), butterfly valves (e.g. GEMÜ R480, GEMÜ R490) or ball valves (e.g. GEMÜ B22, GEMÜ 24) can be used for this purpose.

"In combination with expandable automation components, our valves are technically very well positioned to support and drive forward the new cultivated meat market from the laboratory phase through to commercial production," says Tibor Tot, Business Development Manager in the Pharma, Food & Biotech business unit.